miR-7: An anti-cancer micro RNA miReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company was formed in 2010 through an investment from the Medical Research Commercialisation Fund (MRCF). The Company’s published research shows that miR-7 can knock-out an e...See more
Headquarter Australia |
Year founded 2010 (14 years) |
Funding status Private |
Company type SME |
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Co-founder and Researcher | hidden.item | hidden.item | hidden.item | |||
Co-Founder | hidden.item | hidden.item | hidden.item |